Idazoxan hydrochloride

Research use only, not for human use.

A benzodioxane-linked imidazole that has alpha-2 adrenoceptor antagonist activity.

A benzodioxane-linked imidazole that has alpha-2 adrenoceptor antagonist activity.(In Vivo):Idazoxan (0.16-5 mg/kg; subcutaneous injection; for 1 hour; male CD-COBS rats) treatment potently reverses haloperidol-induced catalepsy with an ED50 of 0.25?mg/kg. Idazoxan (0.3 and 2.5?mg/kg) has no effect on extracellular DA and do not modify the rise of extracellular DA induced by haloperidol.

——

Idazoxan (0.16-5 mg/kg; subcutaneous injection; for 1 hour; male CD-COBS rats) treatment potently reverses haloperidol-induced catalepsy with an ED50 of 0.25?mg/kg. Idazoxan (0.3 and 2.5?mg/kg) has no effect on extracellular DA and do not modify the rise of extracellular DA induced by haloperidol. Animal Model:Male CD-COBS rats injected with 1?mg/kg haloperidol Dosage:0.16 mg/kg, 0.31 mg/kg, 0.63 mg/kg, 1.25 mg/kg, 2.5 mg/kg, and 5.0?mg/kg Administration:Subcutaneous injection; for 1 hour Result:Potently reversed haloperidol-induced catalepsy with an ED50 of 0.25?mg/kg.

——

Endocrinology/Hormones

Adrenergic Receptor

Adrenergic Receptor

Neurological Disease

——

79944-56-2

240.69

C11H12N2O2·HCl

>98% (HPLC)

Water: 100 mM

Cl.C1CN=C(N1)C1COC2=CC=CC=C2O1

——

(-20℃)

With Ice Pack

≥ 2 years